Persistent human papillomavirus infection and cervical neoplasia.
about
ATP stimulates GRK-3 phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptorIndoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspectiveGenetic variations of E6 and long control region of human papillomavirus type 16 from patients with cervical lesion in Liaoning, China.Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low-grade cervical intraepithelial neoplasia.HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinomaGINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancerEffects of photodynamic therapy using topical applied hexylaminolevulinate and methylaminolevulinate upon the integrity of cervical epithelium.Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesionsReduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.Analysis of host-parasite incongruence in papillomavirus evolution using importance sampling.The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis.Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activationType-specific detection of 30 oncogenic human papillomaviruses by genotyping both E6 and L1 genes.Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer.Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement.Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential.Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain.Lung Cancer and Human Papilloma Viruses (HPVs): Examining the Molecular EvidenceMicroanatomy of the cervical and anorectal squamocolumnar junctions: a proposed model for anatomical differences in HPV-related cancer risk.Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia IIIMutant p53: one name, many proteins.The laboratory diagnosis of genital human papillomavirus infections.Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet UnionConfirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping testGeneration and characterization of a preventive and therapeutic HPV DNA vaccineHuman papillomavirus infections and cancer stem cells of tumors from the uterine cervix.Regulation of telomerase and telomeres: human tumor viruses take control.Detention of HPV L1 Capsid Protein and hTERC Gene in Screening of Cervical CancerDifferences in the mutation of the p53 gene in exons 6 and 7 in cervical samples from HIV- and HPV-infected womenCytological and histopathological aspects concerning preinvasive squamous cervical lesionsProteomic identification of potential biomarkers for cervical squamous cell carcinoma and human papillomavirus infection.p16INK4a : A surrogate marker of high-risk human papillomavirus infection in squamous cell carcinoma of the nasal vestibule.Why Human Papillomavirus Acute Infections Matter.Characteristics of cervical disease among symptomatic women with histopathological sample at Hawassa University referral hospital, Southern Ethiopia.[Human papillomavirus and cervical neoplasia].Prevalence of selective inhibition of HPV-16 DNA amplification in cervicovaginal lavages.TP53 codon 72 polymorphism and risk of cervical carcinoma in Serbian women.
P2860
Q24647504-C4E2568F-ACCE-4CE7-9091-4A1CEFD7F6EDQ28388553-31C1881A-7042-431C-95B0-DA62FCE735D3Q31141200-1DD6B4F6-971B-4B3E-B41E-E7B5E8BD7AABQ31160231-C04EFDA8-D307-4413-9F30-40337600C045Q33586269-661B129D-5B15-4085-9BEA-9958F7562FF7Q33674751-01FE90B7-1995-474B-9113-18C6CC9B2380Q33728867-6338599D-95EA-49E9-87B7-B43D44F399DEQ33830609-22EF325F-6D6E-40E6-8085-21B8730FDE0FQ33835617-5F930B18-73A2-438A-9E33-5006B3BA7423Q33860365-2B02FC79-6D26-454A-8695-33E9E4A1722AQ34124022-63E60E49-8192-4396-9CA5-7E7FAFA3986FQ34153391-F44DBB32-CB67-419B-8546-8FF8157E02E6Q34397856-D1F0724F-1E6E-4CB3-B07D-1BB7E8B604B9Q34477097-6C8B7FBD-2AF3-4EF0-8A67-3906B03EFD5AQ34537702-CDFB7184-B982-4D7E-A163-CE6C55DF15D6Q34719623-33834521-DA55-4D94-81D5-0CC0EAA1B37EQ34773451-26A24AE2-4F23-40B6-A158-373ADAA1CD49Q35055665-5420680A-3326-4CD6-ABAB-F2CBC0F62BA4Q35129010-3E5D4659-AB59-4CE8-A2D9-8B79F6788325Q35572951-0D133E72-3011-4487-805C-9C176652ED6AQ35738843-DCDFD0FC-D84E-4782-8384-14FFF188A315Q35812399-8201D4C0-CB51-4899-AF3B-A3D63EBF2FA7Q36052694-AF262D8A-E4B1-4CFB-959A-498CEA453DB1Q36070574-50832734-2A7D-43B0-9433-3F66984D1028Q36171005-4897E683-C9B6-45F3-B0CB-83B82810199DQ36241639-9E1574F0-0943-43BB-8CF6-44F659918313Q36314457-5EA5D30B-EE67-439E-A33E-B3C4E0B0BD98Q36482161-F56F21B8-0A50-4E80-891B-CF6021C20ED3Q36540434-6DC478F7-3792-4D79-9385-C2D261269E2DQ37053343-A375044E-7855-4EAF-A2C1-9DD8DC6E8A60Q37134284-F828BFD6-641C-44B4-BB98-F7E2A8B0EBDEQ37364772-9A292999-8B24-4311-B3D7-5E887D2E0AF0Q37622479-86384551-937C-4095-A564-D470B2C9F034Q38819671-181C1B7E-82B4-47AB-812D-48CD1E75C7A9Q40260945-7CF90897-51E9-4F17-A821-C995C427D70CQ41921051-53BB5310-2373-4D4F-87B8-58D3F7958846Q42368108-5A899366-A1EA-4BE9-8798-395C74E6C869Q43986168-62DB6CD7-F896-46F9-89AC-C212D138BC6BQ44667085-180BA40E-8CF0-4AB7-A412-DD40E01BC001Q45897985-A48C1369-D9C2-4BEC-ADEE-0683217EA8E3
P2860
Persistent human papillomavirus infection and cervical neoplasia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Persistent human papillomavirus infection and cervical neoplasia.
@ast
Persistent human papillomavirus infection and cervical neoplasia.
@en
Persistent human papillomavirus infection and cervical neoplasia.
@nl
type
label
Persistent human papillomavirus infection and cervical neoplasia.
@ast
Persistent human papillomavirus infection and cervical neoplasia.
@en
Persistent human papillomavirus infection and cervical neoplasia.
@nl
prefLabel
Persistent human papillomavirus infection and cervical neoplasia.
@ast
Persistent human papillomavirus infection and cervical neoplasia.
@en
Persistent human papillomavirus infection and cervical neoplasia.
@nl
P1433
P1476
Persistent human papillomavirus infection and cervical neoplasia.
@en
P2093
Alex Ferenczy
P356
10.1016/S1470-2045(01)00617-9
P577
2002-01-01T00:00:00Z